Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

Despite the relevant antitumor efficacy of immunotherapy in advanced non-small cell lung cancer (NSCLC), the results in patients whose cancer harbors activating epidermal growth factor receptor (EGFR) mutations are disappointing. The biological mechanisms underlying immune escape and both unresponsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Passarelli, Anna, Aieta, Michele, Sgambato, Alessandro, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371983/
https://www.ncbi.nlm.nih.gov/pubmed/32760402
http://dx.doi.org/10.3389/fimmu.2020.01479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371983/
https://www.ncbi.nlm.nih.gov/pubmed/32760402
http://dx.doi.org/10.3389/fimmu.2020.01479

Ejemplares similares